title: Does the evidence say a 4-point change in ADAS-cog score is clinically significant?
authors.affiliation: Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada. Electronic address: oremusm@mcmaster.ca.
authors.forename: Mark
authors.initials: M
authors.lastname: Oremus
mesh_terms: D000544:Alzheimer Disease / Q000175:diagnosis* / Q000188:drug therapy; D019317:Evidence-Based Medicine; D006801:Humans; D009483:Neuropsychological Tests; D018697:Nootropic Agents / Q000627:therapeutic use
chemical_list: D018697:Nootropic Agents